Atragen

Atragen

Oncology A lipid-based IV formulation of all-trans retinoic acid–ATRA for acute promyelocytic leukemia and other hematologic malignancies, solid tumors. See Promyelocytic leukemia.
References in periodicals archive ?
Therapeutic candidates included in this analysis: AG-858, AP23573, Avastin, Atragen, BAY 43-9006, Bryostatin-1, Campath, Ceplene, CEP-701, Clofarabine, Cloretazine, Decitabine, FK228, Flavopiridol, Genasense, Gleevec, GVAX, Mylotarg, Multiferon, OSI-461, Phenoxodiol, pentostatin, PEG-Interferon, PKC412, PTK787, Revlimid, Rituxan, SU5416, SCH 54031, Sarasar, Triapine, Tezacitabine, Troxacitabine, Trisenox, valspodar, Velcade, Zamyl, Zarnestra, Xcytrin, XL999
for its drug Atragen, the manufacturer's stock fell seventy-three percent, and the company expected to reduce its work force of eighty-five in order to preserve cash flow in pursuit of approval for other products.
In each company profile the data is divided according to several different sections and subsections: - General information - Collaborations and alliances - Drug development pipeline (drug name, indications, developmental stages, effects of drugs, mechanism of actions, targets, - combinatory treatments, general comments) - Related patents Some of the drugs included in the report: AG-858, AP23573, Avastin, Atragen, BAY 43- 9006, Bryostatin-1, Campath, Ceplene, CEP-701, Clofarabine, Cloretazine, Decitabine, FK228, Flavopiridol, Genasense, Gleevec, GVAX, Mylotarg, Multiferon, OSI-461, Phenoxodiol, pentostatin, PEG-Interferon, PKC412, PTK787, Revlimid, Rituxan, SU5416, SCH 54031, Sarasar, Triapine, Tezacitabine, Troxacitabine, Trisenox, valspodar, Velcade, Zamyl, Zarnestra, Xcytrin, XL999.
In each company profile the data is divided according to several different sections and subsections:- General information - Collaborations and alliances - Drug development pipeline (drug name, indications, developmental stages, effects of drugs, mechanism of actions, targets, - combinatory treatments, general comments) - Related patents Some of the drugs included in the report:AG-858, AP23573, Avastin, Atragen, BAY 43-9006, Bryostatin-1, Campath, Ceplene, CEP-701, Clofarabine, Cloretazine, Decitabine, FK228, Flavopiridol, Genasense, Gleevec, GVAX, Mylotarg, Multiferon, OSI-461, Phenoxodiol, pentostatin, PEG-Interferon, PKC412, PTK787, Revlimid, Rituxan, SU5416, SCH 54031, Sarasar, Triapine, Tezacitabine, Troxacitabine, Trisenox, valspodar, Velcade, Zamyl, Zarnestra, Xcytrin, XL999